urapidil has been researched along with Shock, Cardiogenic in 1 studies
Shock, Cardiogenic: Shock resulting from diminution of cardiac output in heart disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Contargyris, C | 1 |
| Nee, L | 1 |
| Saby, C | 1 |
| Kerbaul, F | 1 |
| Peytel, E | 1 |
1 other study available for urapidil and Shock, Cardiogenic
| Article | Year |
|---|---|
[Phaeochromocytoma revealed by a cardiogenic shock treated by extracorporeal life support].
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Advanced Cardiac Life Support; Hemodynamics; | 2012 |